Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-08-26 | New | $0 | $0 | Other | 06b | SEC link |
| 2020-05-06 | Amended | $37,288,167 | $10,457,174 | Equity Only | 06b | SEC link |
| 2018-12-21 | New | $26,830,993 | $26,830,993 | Equity Only | 06b | SEC link |
| 2018-03-12 | Amended | $23,795,372 | $12,326,154 | Equity Only | 06b | SEC link |
| 2016-04-27 | New | $11,469,218 | $11,469,218 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Douglas Boothe | Director |
| Carrie Busch | Executive |
| Kevin Cameron | Director, Executive |
| David Eve | Executive |
| Nancy Hargreaves | Executive |
| David Martin | Director |
| Gregory Martin | Director |
| Phun Phieu | Executive |
| Anthony Stagnolia | Executive |
| Michael Tarnock | Director |
| Michael Tarnok | Director |
| Gregory Taxin | Director |